Merck Keytruda plus Padcev improves survival in advanced or metastatic urothelial carcinoma Ruchika Sharma24 Sep 2023 10:00 AM GMTRahway: Merck, known as MSD outside of the United States and Canada, has announced positive topline results from the Phase 3 KEYNOTE-A39...
Setback: Merck-Eisai combination therapy fails in lung cancer studies Ruchika Sharma23 Sep 2023 8:51 AM GMTNew Jersy: Drugmakers Merck and Eisai said on Friday a combination of their cancer therapies did not prolong the lives of patients in two...
Merck gets USFDA priority review for Keytruda plus concurrent chemoradiotherapy for cervical cancer Ruchika Sharma21 Sep 2023 12:03 PM GMTRahway: Merck, known as MSD outside of the United States and Canada, has announced the U.S. Food and Drug Administration (FDA) has accepted for...
Merck Welireg get USFDA priority review for certain previously treated patients with Advanced Renal Cell Carcinoma Ruchika Sharma21 Sep 2023 9:18 AM GMTRahway: Merck, known as MSD outside of the United States and Canada, has announced the U.S. Food and Drug Administration (FDA) has accepted and...
Merck gets positive EU CHMP opinion for Keytruda as adjuvant treatment for adults with Non-Small Cell Lung Cancer Ruchika Sharma18 Sep 2023 6:00 AM GMTRahway: Merck, known as MSD outside of the United States and Canada, has announced that the European Medicines Agency’s Committee for Medicinal...
Merck presents new analyses from Sotatercept studies for adults with pulmonary arterial hypertension Ruchika Sharma13 Sep 2023 8:00 AM GMTRahway: Merck, known as MSD outside of the United States and Canada, has announced new analyses from studies of sotatercept, Merck’s novel...
Gilead Sciences Trodelvy, Keytruda combo study demonstrates promising clinical activity in first-line Metastatic Non-Small Cell Lung Cancer Ruchika Sharma12 Sep 2023 9:00 AM GMTFoster City: Gilead Sciences, Inc. has announced promising early data from the global, open-label, Phase 2 EVOKE-02 study evaluating Trodelvy...
Merck, Portage Biotech collaborate to evaluate Portage's next-generation adenosine antagonists in combination with Keytruda in solid tumors Ruchika Sharma10 Sep 2023 6:00 AM GMTWestport: Portage Biotech Inc., a clinical-stage immuno-oncology company advancing novel multi-targeted therapies for use as monotherapy and in...
European Commission expands Merck Ervebo indication to include children 1 year of age and older Ruchika Sharma9 Sep 2023 4:30 AM GMTRahway: Merck, known as MSD outside of the United States and Canada, has announced that the European Commission (EC) has approved an expanded...
Novartis sues US government over Medicare drug price regulation Ruchika Sharma4 Sep 2023 6:01 AM GMTThe pharmaceutical industry says the program will curtail profits and compel it to pull back on developing new treatments.
Merck, Eisai to shut down late stage study for combo cancer therapy Ruchika Sharma28 Aug 2023 7:01 AM GMTThe companies are testing the combination to treat a range of cancers, including those affecting the lungs and stomach.
Merck declares topline results from Phase 3 trial of Welirag Ruchika Sharma19 Aug 2023 10:34 AM GMTRahway: Merck, known as MSD outside of the United States and Canada, has announced topline results from LITESPARK-005, the first positive Phase 3...
